Improved antitumoral treatments

Details for Australian Patent Application No. 2009221120 (hide)

Owner Pharma Mar, S.A.

Inventors Ramon Y Cajal Agueras, Santiago; Jimeno Donaque, Jose Ma; Hernandez Losa, Javier; Raymond, Eric

Agent Shelston IP

Pub. Number AU-A-2009221120

PCT Pub. Number WO2009/109649

Priority 08380078.9 07.03.08 EP

Filing date 6 March 2009

Wipo publication date 11 September 2009

International Classifications

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/404 (2006.01)

A61K 31/436 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/7068 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109649 Priority application(s): WO2009/109649

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221128-Inhibitors for brassinosteroid signalling

2009221114-Use of interleukin-1 conjugates in the treatment of diabetes